High-dose nitrates in the immediate management of unstable angina: Optimal dosage, route of administration, and therapeutic goals

American Journal of Emergency Medicine

Volumn 16, Issue 3, 1998, Pages 219-224

  Cotter, Gad ^a   Faibel, Hedy ^a   Barash, Paul ^e   Shemesh, Eyal ^f   Moshkovitz, Yaron ^b,c   Metzkor, Einat ^a   Simovitz, Avi ^d   Miller, Rami ^d   Schlezinger, Zwi ^a   Golik, Ahuva ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d MAGEN DAVID ADOM   (Israel)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f MOUNT SINAI HOSPITAL   (United States)

Author keywords

Nitrates; Unstable angina

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; ISOSORBIDE DINITRATE; NITRATE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ST SEGMENT DEPRESSION; SUBLINGUAL DRUG ADMINISTRATION; UNSTABLE ANGINA PECTORIS;

EID: 13144262798     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-6757(98)90087-0     Document Type: Article

References (24)

1. The TIMI IIIb investigators: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non Q wave myocardial infarction. Circulation 1994;89:1545-1556
2. Cairns JA, Singer J, Gent M, et al: One year mortality outcomes of all coronary and intensive care unit patients with acute myocardial infarction, unstable angina or other chest pain in Hamilton, Ontario a city of 375,000 people. Can J Cardiol 1989;5:239-246
3. Cannon CP, Thompson BR, McCabe CH, et al: predictors of non-Q wave myocardial infarction in patients with acute ischemic syndromes: An analysis from thrombolysis in myocardial ischemia-TIMI III trails. Am J Cardiol 1995;75:977-981
4. Langer A, Freeman MR, Armstrong PW: ST segment shift in unstable angina: Pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol 1989;13:1495-1502
5. Braunwald E, Mark DB, Jones RH, et al: Unstable angina: Diagnosis and Management. Clinical Practice Guideline Number 10. APHCPR Publication no. 94-0602. Rockville, MD, Agency for Health Care Policy and Research and the National Heart, Lung, and Blood Institute, Public Health Service, U.S. Department of Health and Human Services, March 1994
6. Miller RR, Fennell WH, Young JB, et al: Differential systemic arterial and venous actions and consequent cardiac effects of vasodilator drugs. Prog Cardiovasc Dis 1982;24:353-374
7. Imhof PR, Ott B, Frankhauser P, et al: Difference in nitroglycerin dose response in the venous and arterial beds. Eur J Clin Pharmacol 1980;18:455-460
8. Horwitz LD, Gorlin R, Taylor WJ, Kemp HG: Effects of nitroglycerin on regional myocardial blood flow in coronary artery disease. J Clin Invest 1971;50:1578-1584
9. Bassenge E, Stewart DJ: Effects of nitrates in various vascular sections and regions. Z Kardiol 1986;75:1-7 (suppl 3)
10. Jugdutt BI, Becker LC, Hutchins GM, et al: Effect of intravenous nitroglycerin on collateral blood flow and infarct size in conscious dog. Circulation 1981;63:17-28
11. Jugdutt BI, Warnica JW: Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications: Effect of timing, dosage, and infarct location. Circulation 1988;78:906-919
12. Bussmann WD, Schofer H, Kurita H, Gantz W: Nitroglycerin in acute myocardial infarction. X. Effect of small and large doses of nitroglycerin on sigma ST segment deviation: Experimental and clinical results. Clin Cardiol 1979;2:106-112
13. Nelson GIC, Silke B, Ahuja RC, Hussain M: Haemodynamic advantages of isosorbide dinitrate over furosemide in acute heart failure following myocardial infarction. Lancet 1983;1:730-732
14. Nashed AH, Allegra JR, Larsen S, et al: Bolus IV nitroglycerin treatment of ischemic chest pain in the ED. Am J Emerg Med 1994;12:288-291
15. Hirota Y, Saito T, Kita Y, et al: Intravenous isosorbide dinitrate infusion in the management of unstable angina pectoris refractory to conventional medical therapy. Jpn Circ J 1987;51:617-623
16. Kopman EA, del-Real AF: Bolus intravenous nitroglycerin for ST-depression not associated with increased myocardial oxygen demand. Can Anaesth Soc J 1982;29:539-542
17. Bosc E, Bertinchant JP, Hertault J: Utilisation de la trinitrite injectabale (bolus de 3 mg) dans le traitement de l'edeme pulmonaire cardiogenique. Ann Cardiol Angiol 1982;31:477-480
18. Morrison RA, Weigand UW, Jahnchem E, et al: Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual and percutaneous dosing in angina. Clin Pharmacol Ther 1983;33:747-756
19. DePace NL, Herling IM, Kotler MN, et al: Intravenous nitroglycerin for rest angina, potential pathophysiologic mechanism of action. Arch Intern Med 1982;142:1806-1809
20. Kaplan K, Davison R, Parker M, et al: Intravenous nitroglycerin in the treatment of angina at rest unresponsive to standard nitrate therapy. Am J Cardiol 1983;51:694-698
21. Mikolich JR, Nicholoff NB, Robinson PH, Logue RB: Relief of refractory angina with continuous intravenous infusion of nitroglycerin. Chest 1980;77:375-379
22. Koh KK, Park GS, Song JH, et al: Interaction of intravenous heparin and organic nitrates in acute ischemic syndromes. Am J Cardiol 1995;76:706-709
23. Conti CR. Use of nitrates in unstable angina. Am J Cardiol 1987;60:31H-34H
24. Distante A, Sabino F, L'Abbate A: Cooling down unstable angina with high doses of isosorbide di nitrate (ISDN) continuously infused. Eur Heart J 1988;9:155-164 (suppl A)